Cross sensitization of diet and alcohol on binge behaviors and metabolic dysfunction
饮食和酒精对暴饮暴食行为和代谢功能障碍的交叉敏感性
基本信息
- 批准号:10501123
- 负责人:
- 金额:$ 41.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAlcohol consumptionAlcoholsAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskAmyloidAmyloid depositionApolipoprotein EBehaviorBehavioralBehavioral ModelBlood VesselsBrainCell Surface ReceptorsCerebrospinal FluidCerebrovascular DisordersCerebrumChronicClinicalComplementConsumptionDevelopmentDietDisease ProgressionDisease susceptibilityEnzymesEthanolGenotypeGlucoseGoalsHeterogeneityHigh Density LipoproteinsHigh Fat DietHippocampus (Brain)HistologicHomeostasisHumanHuman bodyImmune responseImpaired cognitionImpairmentInflammationInsulinLinkLipidsLipoprotein (a)LipoproteinsMemoryMetabolicMetabolic PathwayMetabolic dysfunctionMetabolismModelingMolecularMolecular ConformationMonitorMusNeurofibrillary TanglesNeuroimmuneNon-Insulin-Dependent Diabetes MellitusObesityOrganOutcome StudyOxidative StressParentsPathologicPathway interactionsPeripheralPlasmaProtein IsoformsProteinsProteomeProteomicsResolutionRiskRisk FactorsRoleScaffolding ProteinSenile PlaquesSeveritiesShort-Term MemorySurfaceSystemTechnologyTestingTissuesTransgenic MiceVascular DementiaVascular DiseasesWateralcohol use disorderbinge drinkingbinge type behaviorblood glucose regulationcerebrovascularchronic alcohol ingestionclinically relevantcognitive developmentcomorbiditydisease phenotypeearly onsetglucose metabolismglucose tolerancehuman modelimprovedinsulin signalinginsulin tolerancelipid metabolismlipid transportlipidomicsliquid chromatography mass spectrometrymorris water mazemouse modelnanosizedneuroinflammationnew therapeutic targetnovelnovel therapeutic interventionparticlepleiotropismprotein complexresponsescaffold
项目摘要
Summary
Cerebrovascular dysfunction is tightly linked to the deposition of amyloid plaques and neurofibrillary tangles in
the brain; hallmarks of Alzheimer’s disease (AD). High fat diets (HFD) and chronic over-consumption of alcohol
independently result in aberrant lipid metabolism which underlies the vascular dysfunction associated with
obesity, type II diabetes, vascular dementia, and AD. While HFD and alcohol are both linked to the development
of AD, there is limited information on how binge co-consumption of HFD and alcohol impact AD progression and
associated cognitive decline. Our parent R01 utilizes a novel behavioral mouse model of binge co-consumption
of HFD and alcohol which recapitulates clinical findings showing HFD increases alcohol intake and vice versa,
providing a unique behavioral model to dissect the pathways that go awry with over-consumption of HFD and
alcohol and how they impact the development of AD. HFD and chronic alcohol consumption have a profound
impact on the speciation, composition, and function of plasma lipoproteins which modulate multiple metabolic
pathways including systemic immune response, inflammation, glucose metabolism and oxidative stress.
Lipoprotein function are mostly dominated by a handful of dynamic “scaffold” proteins that reside at the water-
lipid interface, in particular apolipoprotein E (APOE) which has three isoforms—APOE2, APOE3, and APOE4.
APOE4 is associated with elevated neuroinflammation and lower rates of cerebral glucose metabolism and
carriers of APOE4 are at substantially elevated risk for early onset and increased severity of AD. We hypothesize
that HFD and chronic alcohol consumption alter the speciation and compositional signatures of APOE-containing
lipoproteins which exacerbates the neuroimmune response and accelerates cognitive decline and development
of AD. Our specific aim is to characterize the impact of binge co-consumption of HFD and alcohol on the
speciation and composition of APOE3 and APOE4-containing lipoproteins and how they modulate the
development of AD. Utilizing transgenic mouse lines susceptible to Alzheimer’s Disease phenotypes with
humanize APOE isoforms, we will determine how co-morbid high fat diet and alcohol binge consumption
modulates memory function, insulin and glucose function, hippocampal neuroinflammation, and plasma
lipoprotein speciation.
概括
脑血管功能障碍与淀粉样斑块和神经原纤维缠结的沉积密切相关
大脑;阿尔茨海默氏病(AD)的特征;高脂肪饮食(HFD)和长期过度饮酒。
独立导致异常的脂质代谢,这是与血管功能障碍相关的基础
肥胖、二型糖尿病、血管性痴呆和阿尔茨海默氏症(AD),而 HFD 和酒精都与该病的发生有关。
对于 AD 的治疗,关于同时摄入 HFD 和酒精如何影响 AD 进展的信息有限,
我们的母体 R01 采用了一种新型的暴饮暴食行为小鼠模型。
HFD 和酒精的关系概括了临床结果,表明 HFD 会增加酒精摄入量,反之亦然,
提供独特的行为模型来剖析因过度消费 HFD 而出错的途径
酒精以及它们如何影响 HFD 和长期饮酒有着深远的影响。
对调节多种代谢的血浆脂蛋白的形态、组成和功能的影响
途径包括全身免疫反应、炎症、葡萄糖代谢和氧化应激。
脂蛋白的功能主要由驻留在水中的少数动态“支架”蛋白主导。
脂质界面,特别是载脂蛋白 E (APOE),它具有三种亚型:APOE2、APOE3 和 APOE4。
APOE4 与神经炎症升高和脑葡萄糖代谢率降低有关
APOE4 携带者 AD 早发和严重程度增加的风险显着升高。
HFD 和长期饮酒会改变含 APOE 的形态和成分特征
脂蛋白会加剧神经免疫反应并加速认知能力下降和发展
我们的具体目标是描述同时食用 HFD 和酒精对 AD 的影响。
含有 APOE3 和 APOE4 的脂蛋白的形态和组成以及它们如何调节
利用易患阿尔茨海默病表型的转基因小鼠品系来开发 AD。
将 APOE 亚型人性化,我们将确定高脂肪饮食和酗酒如何共存
调节记忆功能、胰岛素和葡萄糖功能、海马神经炎症和血浆
脂蛋白形态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yuval Silberman其他文献
Yuval Silberman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yuval Silberman', 18)}}的其他基金
Cross sensitization of diet and alcohol on binge behaviors and metabolic dysfunction
饮食和酒精对暴饮暴食行为和代谢功能障碍的交叉敏感性
- 批准号:
10670928 - 财政年份:2019
- 资助金额:
$ 41.74万 - 项目类别:
Cross sensitization of diet and alcohol on binge behaviors and metabolic dysfunction
饮食和酒精对暴饮暴食行为和代谢功能障碍的交叉敏感性
- 批准号:
10466806 - 财政年份:2019
- 资助金额:
$ 41.74万 - 项目类别:
Engagement of novel noradrenergic and CRF circuit interactions by chronic alcohol
慢性酒精参与新型去甲肾上腺素能和 CRF 回路相互作用
- 批准号:
9215075 - 财政年份:2016
- 资助金额:
$ 41.74万 - 项目类别:
Engagement of novel noradrenergic and CRF circuit interactions by chronic alcohol
慢性酒精参与新型去甲肾上腺素能和 CRF 回路相互作用
- 批准号:
8790879 - 财政年份:2014
- 资助金额:
$ 41.74万 - 项目类别:
Engagement of novel noradrenergic and CRF circuit interactions by chronic alcohol
慢性酒精参与新型去甲肾上腺素能和 CRF 回路相互作用
- 批准号:
8870234 - 财政年份:2014
- 资助金额:
$ 41.74万 - 项目类别:
Engagement of novel noradrenergic and CRF circuit interactions by chronic alcohol
慢性酒精参与新型去甲肾上腺素能和 CRF 回路相互作用
- 批准号:
8790879 - 财政年份:2014
- 资助金额:
$ 41.74万 - 项目类别:
CRF regulation of BNST target control in alcohol withdrawal
CRF 调节 BNST 酒精戒断目标控制
- 批准号:
8059909 - 财政年份:2010
- 资助金额:
$ 41.74万 - 项目类别:
CRF regulation of BNST target control in alcohol withdrawal
CRF 调节 BNST 酒精戒断目标控制
- 批准号:
8320777 - 财政年份:2010
- 资助金额:
$ 41.74万 - 项目类别:
CRF regulation of BNST target control in alcohol withdrawal
CRF 调节 BNST 酒精戒断目标控制
- 批准号:
8153111 - 财政年份:2010
- 资助金额:
$ 41.74万 - 项目类别:
Novel Mechanisms of Ethanol Potentiation of Rat Basolateral Amygdala GABA
乙醇增强大鼠基底外侧杏仁核 GABA 的新机制
- 批准号:
7330054 - 财政年份:2007
- 资助金额:
$ 41.74万 - 项目类别:
相似国自然基金
分子生物学联合CT血管成像研究不同种类酒及饮酒量对猪血管弹性的作用机制
- 批准号:81371548
- 批准年份:2013
- 资助金额:75.0 万元
- 项目类别:面上项目
相似海外基金
Novel hand hygiene product to remove Clostridioides difficile spores
新型手部卫生产品可去除艰难梭菌孢子
- 批准号:
10603462 - 财政年份:2023
- 资助金额:
$ 41.74万 - 项目类别:
Alcohol Use and Mental Health as Predictors of Intimate Partner Violence from Adolescence to Young Adulthood
饮酒和心理健康是从青春期到青年期亲密伴侣暴力的预测因素
- 批准号:
10749253 - 财政年份:2023
- 资助金额:
$ 41.74万 - 项目类别:
Informing alcohol policy: The impact of evidence-based alcohol warnings on consumption
告知酒精政策:基于证据的酒精警告对消费的影响
- 批准号:
10565120 - 财政年份:2023
- 资助金额:
$ 41.74万 - 项目类别:
Patterns and neurocognitive consequences of opioid-alcohol polysubstance use
阿片类酒精多物质使用的模式和神经认知后果
- 批准号:
10659347 - 财政年份:2023
- 资助金额:
$ 41.74万 - 项目类别:
Adult Progression of Adolescent Onset Substance Use Disorder in a High Risk Sample
高风险样本中青少年发作药物使用障碍的成人进展
- 批准号:
10389730 - 财政年份:2022
- 资助金额:
$ 41.74万 - 项目类别: